EUHA_WHITE_HEALTHCARE

EUHA PUblications

EUHA Publications

EUHA is a trusted stakeholder at the European level and advises policymakers on sustainable and excellent healthcare for the European population, highlighting the key role of university hospitals within healthcare systems.

Our Publications

Rethinking Healthcare Systems: A Call for Urgent, Europe-Wide, and EU-Funded Research and Collaboration

Healthcare systems across Europe face major challenges, including workforce shortages, rising costs, demographic shifts, and emerging threats such as climate change and new epidemics. These pressures compromise hospitals' ability to provide timely, high-quality care. To safeguard public health and ensure long-term resilience, EUHA calls for a comprehensive, multi-country transformation focused on integration, prevention, and innovation. In its Position Paper "Rethinking Healthcare Systems” and Declaration, EUHA outlines urgent reforms, highlights the vital role of university hospitals, and presents a strategic action plan to build future-proof, resilient healthcare systems.

File Download Example
EUHA Position Paper on Rethinking Healthcare Systems Download

File Download Example
EUHA Declaration on Rethinking Healthcare Systems Download

University Hospitals as Innovation Hubs and Drivers of Economic and Societal Development in Europe

The EUHA Innovation Network has developed the paper "University Hospitals as Innovation Hubs and Drivers of Economic and Societal Development in Europe" to provide a strategic framework for leveraging university hospitals as drivers of healthcare innovation and medical research. As a living document, it explores solutions for advancing healthcare, optimising knowledge valorisation, and ensuring long-term sustainability. It also identifies key barriers to innovation within academic healthcare settings and outlines the actions needed to overcome these challenges effectively.

File Download Example
EUHA Paper: University Hospitals as Innovation Hubs and Drivers of Economic and Societal Development in Europeon Rethinking Healthcare Systems Download

EUHA Recommendations for the 10th Framework Programme (FP10)

EUHA supports the European Commission's commitment to maintaining Horizon Europe as a self-standing programme tightly connected to the Competitiveness Fund. We agree with the need for ‘a seamless flow from fundamental research to applied research to start-ups to scale-up’. This paper underscores the urgent need to reinforce EU health research and innovation ecosystems by supporting university hospitals as key innovation hubs. It calls for sustained investment, stronger collaboration across sectors, and flexible funding mechanisms that respond to real healthcare needs. The paper puts forward 4 key recommendations to strengthen EU competitiveness, improve patient care, and ensure the sustainability of health systems through strategic support to research and innovation.

File Download Example
EUHA Position Paper: Recommendations for the 10th Framework Programme (Fp10) Download

EU Regulations on Medical Devices and In-vitro Diagnostic Medical Devices

Our regulatory and compliance experts have analysed the impact of the new Medical Device Regulation (MDR) and In Vitro Diagnostic Medical Device Regulation (IVDR) — Regulations (EU) 2017/745 and 2017/746 — on the innovation capacity of university hospitals. EUHA submitted its recommendations to the European Commission as part of its targeted evaluation of the EU regulatory framework for medical devices and in vitro diagnostics. The Commission’s adoption of any resulting changes is expected by the fourth quarter of 2025.

Coming Soon

EUHA Position: Artificial Intelligence


EUHA recognises the significant potential of Artificial Intelligence (AI) to enhance the quality and efficiency of healthcare. Our experts are currently engaged in discussions to ensure the responsible and optimal application of AI within the healthcare sector.

EUHA Position: Development of Advanced Therapy Medicinal Products (ATMPs)


A group of EUHA experts on advanced innovative therapies is currently focusing on the regulatory hurdles that prevent the clinical development of Advanced Therapy Medicinal products in academic settings.

Related news